We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSFL
2101
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$1.17M ﹤0.01%
50,881
-81,976
-62% -$1.92M
TCP
2102
DELISTED
TC Pipelines LP
TCP
$1.17M ﹤0.01%
31,073
+10,365
+50% +$379K
TEI
2103
Templeton Emerging Markets Income Fund
TEI
$322M
$1.17M ﹤0.01%
114,257
+35,010
+44% +$355K
PRAH
2104
DELISTED
PRA Health Sciences, Inc.
PRAH
$1.17M ﹤0.01%
11,779
-19,500
-62% -$1.86M
CCD
2105
Calamos Dynamic Convertible & Income Fund
CCD
$746M
$1.17M ﹤0.01%
57,942
+212
+0.4% +$4.21K
HYS icon
2106
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.77B
$1.17M ﹤0.01%
11,601
-1,169
-9% -$117K
CTR
2107
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$1.16M ﹤0.01%
24,781
-772
-3% -$36.8K
TRNS icon
2108
Transcat
TRNS
$909M
$1.16M ﹤0.01%
45,367
+5,448
+14% +$133K
SCHO icon
2109
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
$1.16M ﹤0.01%
+45,804
New +$1.15M
BCPC
2110
Balchem Corp
BCPC
$5.7B
$1.16M ﹤0.01%
11,593
+175
+2% +$17K
IBDR icon
2111
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.38B
$1.16M ﹤0.01%
46,222
+610
+1% +$14.9K
VSAT icon
2112
Viasat
VSAT
$11.6B
$1.14M ﹤0.01%
+14,161
New +$1.24M
HTHT icon
2113
Huazhu Hotels Group
HTHT
$12.8B
$1.14M ﹤0.01%
31,504
+1,686
+6% +$63.1K
CASH icon
2114
Pathward Financial
CASH
$1.82B
$1.14M ﹤0.01%
40,637
-129,567
-76% -$3.3M
GDEN
2115
DELISTED
Golden Entertainment
GDEN
$1.14M ﹤0.01%
81,372
-5,374
-6% -$78.2K
IOO icon
2116
iShares Global 100 ETF
IOO
$9.46B
$1.14M ﹤0.01%
23,330
-1,385
-6% -$67K
CALF icon
2117
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.87B
$1.14M ﹤0.01%
47,900
-5,755
-11% -$140K
FTDR icon
2118
Frontdoor
FTDR
$5.81B
$1.14M ﹤0.01%
+26,124
New +$1M
MMU
2119
Western Asset Managed Municipals Fund
MMU
$552M
$1.14M ﹤0.01%
83,040
+3,891
+5% +$52.6K
VREX icon
2120
Varex Imaging
VREX
$779M
$1.14M ﹤0.01%
37,090
+2,096
+6% +$64K
LW icon
2121
Lamb Weston
LW
$7.16B
$1.13M ﹤0.01%
17,829
+169
+1% +$11.1K
SNDR icon
2122
Schneider National
SNDR
$6.22B
$1.13M ﹤0.01%
61,763
+6,984
+13% +$135K
AA icon
2123
Alcoa
AA
$14.1B
$1.13M ﹤0.01%
48,054
-1,376
-3% -$34.3K
JWN
2124
DELISTED
Nordstrom
JWN
$1.12M ﹤0.01%
35,288
-38,262
-52% -$1.44M
DTV
2125
DELISTED
DTE Energy Company 2016 Corporate Units
DTV
$1.12M ﹤0.01%
20,000

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.